CAV3 gene mutation analysis in patients with idiopathic hyper-CK-emia
Related Experiment Video
Updated: Aug 7, 2026
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Jaap C Reijneveld1, Ieke B Ginjaar, Wendy S Frankhuizen
1Department of Neurology, VU University Medical Center, ZH 2A.87, 1007 MB Amsterdam, The Netherlands. jc.reijneveld@vumc.nl
Insights
Genetic analysis of the CAV3 gene revealed variants in two patients with persistent hyper-CK-emia. These findings suggest potential caveolin-3 dysfunction contributing to unexplained high creatine kinase levels.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Persistent hyper-CK-emia (high creatine kinase levels) often lacks a clear cause.
- Caveolin-3 is a protein crucial for muscle cell membrane function.
- Deficiencies in caveolin-3 have been implicated in muscle disorders.
Purpose of the Study:
- To investigate the role of CAV3 gene mutations in patients with idiopathic hyper-CK-emia.
- To determine if CAV3 gene variants explain persistent elevation of creatine kinase levels.
- To assess caveolin-3 protein localization in muscle tissue of affected individuals.
Main Methods:
- Conducted CAV3 gene mutation analysis in 31 patients with idiopathic hyper-CK-emia.
- Performed immunohistochemistry for caveolin-3 protein on muscle tissue samples.
- Analyzed blood samples from 29 patients for genetic variants.
Main Results:
- CAV3 gene variants were identified in 2 out of 29 patients.
- Immunohistochemistry showed proper localization of caveolin-3 in muscle tissue of affected patients.
- Despite correct localization, caveolin-3 may not be functioning normally in these patients.
Conclusions:
- CAV3 gene mutation analysis can contribute to understanding unexplained persistent hyper-CK-emia.
- Potential caveolin-3 dysfunction, despite normal localization, may explain elevated creatine kinase.
- Further research is required before routine clinical use of CAV3 gene analysis for hyper-CK-emia.
Abstract:
As caveolin-3 deficiencies may explain persistent hyper-CK-emia, we performed CAV3 gene mutation analysis and immunohistochemistry for caveolin-3 in 31 patients with idiopathic hyper-CK-emia. In 2 of 29 patients who donated blood, variants in the CAV3 gene were detected. Although immunohistochemical analysis strongly suggested that caveolin-3 was properly localized in the muscle tissue of the two affected patients, it may not function normally and could thus explain their persistent hyper-CK-emia. Our findings contribute to the clarification of unexplained persistent hyper-CK-emia, but further research is needed before CAV3 gene mutation analysis becomes part of the routine evaluation of these patients.
